Clinical Trials Directory

Trials / Completed

CompletedNCT04896489

Neuroimaging Mechanisms by Which Memory and Glucocorticoids Promote Risky Drinking

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether hydrocortisone biases formation of alcohol-related memories to potentiate drinking.

Detailed description

This study aims to 1) Characterize the effect of elevated glucocorticoids during encoding on long-term memory for alcohol-related information; 2) Identify the neural mechanisms by which glucocorticoids influence encoding of alcohol-related experiences; and 3) Determine how glucocorticoid modulation of alcohol-related encoding relates to drinking after retrieving alcohol-related memories.

Conditions

Interventions

TypeNameDescription
DRUGHydrocortisone 20 MGParticipants receive Hydrocortisone 20 MG
OTHERPlaceboParticipants receive placebo

Timeline

Start date
2021-05-12
Primary completion
2022-03-15
Completion
2022-03-15
First posted
2021-05-21
Last updated
2022-06-02

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04896489. Inclusion in this directory is not an endorsement.